Institutions Holding Call Options on Arcutis Biotherapeutics, Inc. (ARQT)
This table provides information about the call option holders of Arcutis Biotherapeutics, Inc. (ARQT). We have compiled data on the institutions that hold call options on the stock, with a total of 5.43 Million call options outstanding, which have been reported (via 13F filing form) to have a value of $49.7 Million at the end of the reported quarter. These call option holders have the right, but not the obligation, to buy AAPL shares at a specified price within a certain time frame.
| Holding | Report Date | calls Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Stem Point Capital LP
New York, NY |
Aug 13, 2024 Q2 2024 |
5,000,000
calls
|
$46.8 Million
0.1% of portfolio
|
Q2 2024
Reduced 90.0%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Aug 15, 2024 Q2 2024 |
162,300
calls
|
$1.52 Million
0.0% of portfolio
|
N/A
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2024 Q2 2024 |
80,300
calls
|
$751,608
0.0% of portfolio
|
N/A
|
|
|
Caption Management, LLC
Oklahoma City, OK |
Aug 14, 2024 Q2 2024 |
74,300
calls
|
$695,448
0.01% of portfolio
|
N/A
|
|
|
Barclays PLC
London, X0 |
Aug 14, 2024 Q2 2024 |
71,700
calls
|
$671,112
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Jefferies Financial Group Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
40,500
calls
|
$379,080
0.0% of portfolio
|
Q2 2024
New holding
|